The FDA said the company is taking the action because of a potential risk of patients developing progressive multifocal leukoencephalopathy -- a rare, serious, progressive neurologic disease caused by a virus that affects the central nervous system." [UPI]
Monday, April 13, 2009
Raptiva is withdrawn from the U.S. market - UPI.com
Raptiva is withdrawn from the U.S. market - UPI.com: "The U.S. Food and Drug Administration says Genentech Inc. (NYSE:DNA) is withdrawing the psoriasis drug Raptiva and it will no longer be available in the United States.
The FDA said the company is taking the action because of a potential risk of patients developing progressive multifocal leukoencephalopathy -- a rare, serious, progressive neurologic disease caused by a virus that affects the central nervous system." [UPI]
The FDA said the company is taking the action because of a potential risk of patients developing progressive multifocal leukoencephalopathy -- a rare, serious, progressive neurologic disease caused by a virus that affects the central nervous system." [UPI]
